<VariationArchive RecordType="classified" VariationID="198735" VariationName="NM_000487.6(ARSA):c.1408_1418del (p.Ala470fs)" VariationType="Deletion" Accession="VCV000198735" Version="8" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-04-02" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="190193" VariationID="198735">
      <GeneList>
        <Gene Symbol="ARSA" FullName="arylsulfatase A" GeneID="410" HGNC_ID="HGNC:713" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="50622754" stop="50628152" display_start="50622754" display_stop="50628152" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="51061181" stop="51066600" display_start="51061181" display_stop="51066600" Strand="-" />
          </Location>
          <OMIM>607574</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000487.6(ARSA):c.1408_1418del (p.Ala470fs)</Name>
      <CanonicalSPDI>NC_000022.11:50625256:GTCACAGCTGCGTC:GTC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="50625257" stop="50625267" display_start="50625257" display_stop="50625267" variantLength="11" positionVCF="50625256" referenceAlleleVCF="GGTCACAGCTGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="51063685" stop="51063695" display_start="51063685" display_stop="51063695" variantLength="11" positionVCF="51063684" referenceAlleleVCF="GGTCACAGCTGC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A384fs</ProteinChange>
      <ProteinChange>A470fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000487.5" sequenceAccession="NM_000487" sequenceVersion="5" change="c.1408_1418del11">
            <Expression>NM_000487.5:c.1408_1418del11</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009260.2" sequenceAccession="NG_009260" sequenceVersion="2" change="g.7913_7923del">
            <Expression>NG_009260.2:g.7913_7923del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000487.6" sequenceAccession="NM_000487" sequenceVersion="6" change="c.1408_1418del" MANESelect="true">
            <Expression>NM_000487.6:c.1408_1418del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000478.3" sequenceAccession="NP_000478" sequenceVersion="3" change="p.Ala470fs">
            <Expression>NP_000478.3:p.Ala470fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001085425.3" sequenceAccession="NM_001085425" sequenceVersion="3" change="c.1408_1418del">
            <Expression>NM_001085425.3:c.1408_1418del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001078894.2" sequenceAccession="NP_001078894" sequenceVersion="2" change="p.Ala470fs">
            <Expression>NP_001078894.2:p.Ala470fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001085426.3" sequenceAccession="NM_001085426" sequenceVersion="3" change="c.1408_1418del">
            <Expression>NM_001085426.3:c.1408_1418del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001078895.2" sequenceAccession="NP_001078895" sequenceVersion="2" change="p.Ala470fs">
            <Expression>NP_001078895.2:p.Ala470fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001085427.3" sequenceAccession="NM_001085427" sequenceVersion="3" change="c.1408_1418del">
            <Expression>NM_001085427.3:c.1408_1418del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001078896.2" sequenceAccession="NP_001078896" sequenceVersion="2" change="p.Ala470fs">
            <Expression>NP_001078896.2:p.Ala470fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001085428.3" sequenceAccession="NM_001085428" sequenceVersion="3" change="c.1150_1160del">
            <Expression>NM_001085428.3:c.1150_1160del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001078897.1" sequenceAccession="NP_001078897" sequenceVersion="1" change="p.Ala384fs">
            <Expression>NP_001078897.1:p.Ala384fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362782.2" sequenceAccession="NM_001362782" sequenceVersion="2" change="c.1150_1160del">
            <Expression>NM_001362782.2:c.1150_1160del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001349711.1" sequenceAccession="NP_001349711" sequenceVersion="1" change="p.Ala384fs">
            <Expression>NP_001349711.1:p.Ala384fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.51063688_51063698del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.51063688_51063698del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.50625260_50625270del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.50625260_50625270del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA278517" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607574.0007" DB="OMIM" />
        <XRef Type="rs" ID="80338823" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000487.6(ARSA):c.1408_1418del (p.Ala470fs) AND Metachromatic leukodystrophy" Accession="RCV000180166" Version="6">
        <ClassifiedConditionList TraitSetID="787">
          <ClassifiedCondition DB="MedGen" ID="C0023522">Metachromatic leukodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000487.6(ARSA):c.1408_1418del (p.Ala470fs) AND not provided" Accession="RCV000723834" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-06-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000487.6(ARSA):c.1408_1418del (p.Ala470fs) AND Metachromatic leukodystrophy, late infantile form" Accession="RCV002265665" Version="1">
        <ClassifiedConditionList TraitSetID="784">
          <ClassifiedCondition DB="MedGen" ID="C0751278">Metachromatic leukodystrophy, late infantile form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1991-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2014-06-13" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1676699</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ARSA</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301309</ID>
          <ID Source="BookShelf">NBK1130</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="784" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9033" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Metachromatic leukodystrophy, late infantile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Metachromatic leukodystrophy, late infantile form</ElementValue>
                <XRef ID="MONDO:0017729" DB="MONDO" />
              </Name>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="309256" DB="Orphanet" />
              <XRef ID="C0751278" DB="MedGen" />
              <XRef ID="MONDO:0017729" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="787" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5508" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Metachromatic leukoencephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sulfatide lipidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral sclerosis diffuse metachromatic form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroside sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arylsulfatase A Deficiency</ElementValue>
                <XRef ID="NBK1130" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Metachromatic leukodystrophy</ElementValue>
                <XRef ID="Metachromatic+leukodystrophy/4691" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018868" DB="MONDO" />
                <XRef ID="396338004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MLD</ElementValue>
                <XRef Type="MIM" ID="250100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile MLD, juvenile MLD, and adult MLD. Age of onset within a family is usually similar. The disease course may be from several years in the late-infantile-onset form to decades in the juvenile- and adult-onset forms. Late-infantile MLD. Onset is before age 30 months. Typical presenting findings include weakness, hypotonia, clumsiness, frequent falls, toe walking, and dysarthria. As the disease progresses, language, cognitive, and gross and fine motor skills regress. Later signs include spasticity, pain, seizures, and compromised vision and hearing. In the final stages, children have tonic spasms, decerebrate posturing, and general unawareness of their surroundings. Juvenile MLD. Onset is between age 30 months and 16 years. Initial manifestations include decline in school performance and emergence of behavioral problems, followed by gait disturbances. Progression is similar to but slower than in the late-infantile form. Adult MLD. Onset occurs after age 16 years, sometimes not until the fourth or fifth decade. Initial signs can include problems in school or job performance, personality changes, emotional lability, or psychosis; in others, neurologic symptoms (weakness and loss of coordination progressing to spasticity and incontinence) or seizures initially predominate. Peripheral neuropathy is common. Disease course is variable – with periods of stability interspersed with periods of decline – and may extend over two to three decades. The final stage is similar to earlier-onset forms.</Attribute>
                <XRef ID="NBK1130" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301309</ID>
                <ID Source="BookShelf">NBK1130</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="512" DB="Orphanet" />
              <XRef ID="C0023522" DB="MedGen" />
              <XRef ID="MONDO:0018868" DB="MONDO" />
              <XRef Type="MIM" ID="250100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23358" SubmissionDate="2013-03-13" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607574.0007_METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE" title="ARSA, 11-BP DEL, EX8_METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE" />
        <ClinVarAccession Accession="SCV000023358" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1991-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Bohne et al. (1991) demonstrated an 11-bp deletion in exon 8 of one allele of the ARSA gene in a patient with the late infantile form of MLD (250100). Although this allele produced normal amounts of mRNA, no arylsulfatase A crossreacting material could be detected in cultured fibroblasts from the patient. The 11-bp deletion was found between nucleotides 2506 and 2516. It caused a frameshift downstream of the codon for amino acid 467. The polypeptide encoded by the mutant allele should be 29 amino acids longer than wildtype ASA. The other allele, which had been inherited from the father, had a splice donor site mutation in exon 7. This allele is known also to generate no ASA polypeptide. Thus, this was another example where absence of ASA polypeptide correlated with the severe late infantile form of MLD.</Attribute>
              <Citation>
                <ID Source="PubMed">1676699</ID>
              </Citation>
              <XRef DB="OMIM" ID="250100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSA" />
          </GeneList>
          <Name>ARSA, 11-BP DEL, EX8</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">11-BP DEL, EX8</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607574.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="420880" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="16165_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000232556" DateUpdated="2018-12-15" DateCreated="2015-06-28" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-06-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSA" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="22" alternateAllele="-" referenceAllele="GTCACAGCTGC" start="51063685" stop="51063695" variantLength="11" />
            <GeneLocation>NM_000487.5:Ex8</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000487.5:c.1408_1418del11</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="HGMD" ID="CD910478" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ARSA</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="40690" SubmissionDate="2022-07-29" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_000487.5:c.1408_1418del|MedGen:C0023522" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000040690" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1130</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000487.5:c.1408_1418del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023522" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB11826408</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="420880" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23358" TraitType="Disease" MappingType="Name" MappingValue="METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE" MappingRef="Preferred">
        <MedGen CUI="C0751278" Name="Metachromatic leukodystrophy, late infantile form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="40690" TraitType="Disease" MappingType="XRef" MappingValue="C0023522" MappingRef="MedGen">
        <MedGen CUI="C0023522" Name="Metachromatic leukodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

